ARIA-EAACI statement on asthma and COVID-19 (June 2, 2020)
Open Access
- 1 March 2021
- Vol. 76 (3), 689-697
- https://doi.org/10.1111/all.14471
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- The impact of COPD and smoking history on the severity of COVID‐19: A systemic review and meta‐analysisJournal of Medical Virology, 2020
- Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, ItalyJAMA, 2020
- Critical Care Utilization for the COVID-19 Outbreak in Lombardy, ItalyJAMA, 2020
- Distinct characteristics of COVID‐19 patients with initial rRT‐PCR‐positive and rRT‐PCR‐negative results for SARS‐CoV‐2Allergy, 2020
- From Containment to Mitigation of COVID-19 in the USJAMA, 2020
- Hospitalization Rates and Characteristics of Patients Hospitalized with Laboratory-Confirmed Coronavirus Disease 2019-COVID-NET, 14 States, March 1-30, 2020Morbidity and Mortality Weekly Report (MMWR), 2020
- Type 2 and interferon inflammation strongly regulate SARS-CoV-2 related gene expression in the airway epitheliumPublished by Cold Spring Harbor Laboratory ,2020
- Intranasal corticosteroids in allergic rhinitis in COVID‐19 infected patients: An ARIA‐EAACI statementAllergy, 2020
- The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2Nature Microbiology, 2020
- Eleven faces of coronavirus disease 2019Allergy, 2020